Mayne Pharma Group Ltd

HG6

Company Profile

  • Business description

    Mayne Pharma Group Ltd is a specialty pharmaceutical company focused on commercializing novel and generic pharmaceuticals It has a Forty-year track record of innovation and success in developing oral drug delivery systems. The Company's Business consists of three operating segments being International, Women’s Health and Dermatology. The Dermatologysegment distributes dermatology products (branded and generic) in the U.S. on a portfolio basis, The Women’s Health segment distributes branded women’s health products in the U.S. International’s segment revenue and gross profit are derived principally from the Australian manufacture and sale of branded and generic pharmaceutical products.

  • Contact

    1538 Main North Road
    Salisbury South
    SalisburySA5106
    AUS

    T: +61 882092666

    https://www.maynepharma.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - General

    Fiscal Year End

    30 June 2026

    Employees

    160

Stocks News & Analysis

stocks

Are there signs of an AI bubble in Nvidia’s earnings?

Our view after third-quarter results.
stocks

Picking dividend shares in 2026? Here’s where to look

A new report from Morningstar shows opportunities for income investors.
stocks

Ahead of earnings, is Nvidia a buy, a sell, or fairly valued?

With outstanding long-term estimates, here’s what we think of Nvidia stock.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,686.308.30-0.10%
CAC 407,989.448.370.10%
DAX 4023,091.87186.98-0.80%
Dow JONES (US)46,245.41493.151.08%
FTSE 1009,531.013.360.04%
HKSE25,220.02615.55-2.38%
NASDAQ22,273.08195.030.88%
Nikkei 22548,625.881,198.06-2.40%
NZX 50 Index13,419.4020.00-0.15%
S&P 5006,602.9964.230.98%
S&P/ASX 2008,416.500.000.00%
SSE Composite Index3,834.8996.16-2.45%

Market Movers